A phase II randomised study of cisplatinum and nifedipine in end stage carcinoma of the head and neck

http://isrctn.org/> ◽

10.1186/isrctn76747656 ◽

2012 ◽

Author(s):

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Randomised Study ◽

Download Full-text

A phase II randomised study of acupuncture-like transcutaneous nerve stimulation (ALTENS) for the prevention of radiation-induced xerostomia in patients receiving radical radiotherapy for head and neck cancer

Focus on Alternative and Complementary Therapies ◽

10.1111/j.2042-7166.2007.tb05914.x ◽

2007 ◽

Vol 12 ◽

pp. 43-44 ◽

Author(s):

SM Sagar ◽

RK Wong ◽

P Lee ◽

B Chen ◽

G Yi ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Nerve Stimulation ◽

Radical Radiotherapy ◽

Randomised Study ◽

Transcutaneous Nerve Stimulation ◽

Radiation Induced

Download Full-text

A Phase II study of cisplatinum versus cisplatinum + nifedipine in end-stage carcinoma of the head and neck

Clinical Otolaryngology ◽

10.1111/j.1365-2273.1992.tb01705.x ◽

1992 ◽

Vol 17 (6) ◽

pp. 501-504 ◽

Author(s):

A. S. JONES ◽

D. E. PHILLIPS ◽

J. K. FIELD

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Phase Ii Study ◽

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123209.580347 ◽

2008 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Advanced Head ◽

Radiotherapy Dose ◽

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3359960.3049058 ◽

2010 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Prospective Trial ◽

Advanced Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Apatinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Single-Arm, Phase II Study

SSRN Electronic Journal ◽

10.2139/ssrn.3675449 ◽

2020 ◽

Author(s):

Guopei Zhu ◽

Lin Zhang ◽

Shengjin Dou ◽

Rongrong Li ◽

Jiang Li ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Study ◽

Download Full-text

Implication of AV node blockers in patients with end-stage renal disease undergoing head and neck surgery; BRASH syndrome: a case report

Brazilian Journal of Anesthesiology (English Edition) ◽

10.1016/j.bjane.2021.04.031 ◽

2021 ◽

Author(s):

Ju Ik Park ◽

Moon Sik Jung ◽

Hyunho Lee ◽

Hochang Kim ◽

Jimi Oh

Keyword(s):

Case Report ◽

Renal Disease ◽

Head And Neck ◽

End Stage Renal Disease ◽

Neck Surgery ◽

Head And Neck Surgery ◽

Av Node ◽

Stage Renal Disease ◽

Download Full-text

393TiP A phase II trial of nedaplatin, 5-fluorouracil and docetaxel for induction chemotherapy with local advanced squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1016/s0923-7534(21)00551-2 ◽

2016 ◽

Vol 27 ◽

pp. ix121-ix122

Author(s):

S. Ueda ◽

D. Nishikawa ◽

K. Yane ◽

Y. Akashi ◽

T. Sakiyama ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Advanced Squamous Cell Carcinoma ◽

Download Full-text